BO
NVO

Bank OZK’s Novo Nordisk NVO Stock Holding History

Bank OZK’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,182
Closed -$360K – 148
2025
Q1 		$360K Sell
5,182
-16,331
-76% -$1.35M 0.15% 108
2024
Q4 		$1.85M Sell
21,513
-416
-2% -$45K 0.77% 48
2024
Q3 		$2.61M Sell
21,929
-21
-0.1% -$2.8K 1.08% 27
2024
Q2 		$3.13M Buy
21,950
+7,148
+48% +$947K 1.36% 15
2024
Q1 		$1.9M Buy
+14,802
New +$1.76M 0.85% 37
2015
Q3 		– Sell
-7,934
Closed -$217K – 122
2015
Q2 		$217K Sell
7,934
-180
-2% -$5.06K 0.08% 115
2015
Q1 		$217K Buy
+8,114
New +$187K 0.08% 120
2014
Q2 		– Sell
-11,810
Closed -$270K – 127
2014
Q1 		$270K Sell
11,810
-420
-3% -$8.95K 0.1% 98
2013
Q4 		$226K Buy
+12,230
New +$213K 0.09% 104

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Bank OZK's NVO Position: Q2 2025 in Review

Bank OZK sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 5,182 shares — an estimated $360K sold.

Bank OZK first reported a position in NVO in Q4 2013 and held it in 9 quarters. The position peaked at $3.13M in Q2 2024. 1,482 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Bank OZK reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Bank OZK sold 5,182 Novo Nordisk shares in Q2 2025, an estimated $360K.
  • Bank OZK first reported a position in Novo Nordisk in Q4 2013 and held it in 9 quarters.
  • Bank OZK's Novo Nordisk position peaked at $3.13M in Q2 2024.
  • 1,482 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Bank OZK's 13F filing for Q2 2025, filed 12 Aug 2025.